Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      IMAX CORPORATION REPORTS Q4 AND FULL-YEAR 2022 RESULTS

      IMAX Logo. (PRNewsFoto/IMAX Corporation)

      News provided by

      IMAX Corporation

      Feb 22, 2023, 16:05 ET

      Share this article

      Share this article


      • IMAX expects return to pre-pandemic gross box office level of $1.1 billion in 2023 as year begins with strong reopening of China and record-breaking performance of "Avatar: The Way of Water" of approximately $250 million in global box office
          
      • IMAX drives record-breaking Chinese New Year box office of $61.3 million in 2023, led by "The Wandering Earth 2" — now the highest grossing Chinese film of all time in IMAX
          
      • IMAX global entertainment technology platform drives full-year 2022 growth of more than 15% across Revenue, Gross Margin and Adjusted EBITDA(1)
          
      • IMAX gross global box office increased 33% year over year to $850 million leading to record share of both global (3.3%) and domestic (4.8%) gross box office in 2022
          
      • IMAX completes 92 technology system installations for full year 2022 — including 52 in Q4 exceeding mid-range of full year guidance of 80 to 100
          
      • IMAX repurchased 5.4 million shares for full-year 2022 or 9.2% of total shares outstanding

      NEW YORK, Feb. 22, 2023 /PRNewswire/ -- IMAX Corporation (NYSE: IMAX) today reported solid financial results for the fourth quarter of 2022 demonstrating the value of its unique global entertainment technology platform and content portfolio. 

      Continue Reading
      An infographic highlighting IMAX's recent quarter.
      An infographic highlighting IMAX's recent quarter.

      "IMAX fully expects to resume pre-pandemic levels of performance in 2023, as we surge into the year with strong dual tailwinds — the record-breaking performance of 'Avatar: The Way of Water' and the rapid reopening of China," said Richard L. Gelfond, Chief Executive Officer of IMAX. "Already in the new year, we've delivered our highest grossing first-run release ever with the 'Avatar' sequel, our best Chinese New Year box office ever, and multi-system agreements — demonstrating our prospects for strong box office and global network growth in 2023."

      "The first 'Avatar' took IMAX to a new level, and we are seeing early signs that its sequel will help drive growth across our business. 'Avatar: The Way of Water' is our highest grossing release ever in nearly 50 international markets, many of which are underrepresented with IMAX systems and among those we've identified for strategic expansion. Coupled with a strong, consistent Hollywood slate and our expanding local language content portfolio in priority markets, we see a clear opportunity to further expand and diversify our global footprint this year."

      "The rapid reopening of China has been stunning and a powerful reminder of what we can deliver in the market given the strength of our brand, experience, and content portfolio of Hollywood and local blockbusters. With Hollywood tentpoles like 'Avatar: The Way of Water' and 'Ant-Man and the Wasp: Quantumania' gaining day-and-date Chinese releases, and Chinese-made blockbusters like 'The Wandering Earth 2' and 'Full River Red' drawing big audiences, China is fast reasserting itself as one of the world's biggest moviegoing markets."

      Fourth Quarter and December Full-Year Financial Highlights




      Three Months Ended


      Year Ended



      December 31,


      December 31,

      In millions of U.S. Dollars, except per share data


      2022



      2021



      YoY %
      Change


      2022



      2021



      YoY %
      Change

      Total Revenue


      $

      98.0



      $

      108.6



      (10 %)


      $

      300.8



      $

      254.9



      18 %


















      Gross Margin


      $

      48.8



      $

      64.0



      (24 %)


      $

      156.4



      $

      134.4



      16 %

      Gross Margin (%)



      50

      %



      59

      %





      52

      %



      53

      %




















      Net Income (Loss)(2)(3)


      $

      2.6



      $

      10.1



      (74 %)


      $

      (22.8)



      $

      (22.3)



      N/A

      Net Income (Loss) per share(2)(3)


      $

      0.05



      $

      0.17



      (71 %)


      $

      (0.40)



      $

      (0.38)



      N/A

      Adjusted Net Income (Loss)(1)(2)(3)


      $

      10.6



      $

      18.4



      (43 %)


      $

      3.2



      $

      (8.4)



      N/A

      Adjusted Net Income (Loss) per share(1)(2)(3)


      $

      0.19



      $

      0.31



      (39 %)


      $

      0.06



      $

      (0.14)



      N/A


















      Adjusted EBITDA per Credit Facility(1)(4)

      $

      27.8



      $

      44.0



      (37 %)


      $

      84.5



      $

      68.6



      23 %

      Adjusted EBITDA Margin (%)(1)(2)



      30.6

      %



      45.0

      %


      (32 %)



      30.2

      %



      31.0

      %


      (3 %)

      Weighted average shares outstanding (in millions):

      Basic



      54.8




      58.9



      (7 %)



      56.7




      59.1



      (4 %)

      Diluted



      55.7




      59.8



      (7 %)



      57.4




      59.1



      (3 %)

      _______________

      (1)

      Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.



      (2)

      Attributable to common shareholders.



      (3)

      Includes a tax valuation allowance resulting in a negative impact of $2.1 million or $0.04 per share for the three months ended December 31, 2022 (2021 — $0.5 million or $0.01 per share) and $16.5 million or $0.29 per share for the year ended December 31, 2022 (2021 — $14.7 million or $0.25 per share).



      (4)

      Adjusted EBITDA per Credit facility attributable to common shareholders.

      Fourth Quarter and December Year-to-Date Segment Results(1)




      IMAX Technology Network



      IMAX Technology Sales and Maintenance
























      Revenue



      Gross Margin



      Gross
      Margin %



      Revenue



      Gross Margin



      Gross
      Margin %


      4Q22


      $

      45.9



      $

      27.0




      59

      %


      $

      48.0




      $

      23.2




      48

      %

      4Q21


      51.3




      36.8




      72

      %


      53.4





      26.2




      49

      %

      % change



      (11)

      %



      (27)

      %






      (10)

      %




      (11)

      %
























      YTD 4Q22


      $

      156.6



      $

      95.4




      61

      %


      $

      130.6




      $

      63.6




      49

      %

      YTD 4Q21


      116.8




      66.5




      57

      %



      126.8





      64.3




      51

      %

      % change



      34

      %



      43

      %






      3

      %




      (1)

      %




      _______________

      (1)

      Please refer to the Company's Form 10-K for the year ended December 31, 2022 for additional segment information.

      IMAX Technology Network

      • IMAX Technology Network revenues decreased 11% to $45.9 million in the fourth quarter of 2022. Box office from IMAX locations in Q4 of $252 million was down 9.3% from Q4 of 2021 driven by China. Avatar delivered $140 million in box office in the last two weeks of December with 11% market share on less than 1% of screens and comprising more than half of Q4's total IMAX box office.
      • Gross margin for the IMAX Technology Network was $27.0 million in the fourth quarter of 2022, compared to $36.8 million in the prior year period driven by lower revenues and higher marketing investments.

      IMAX Technology Sales and Maintenance

      • IMAX Technology Sales and Maintenance revenues and gross margin decreased 10% to $48.0 million and 11% to $23.2 million, respectively, in the fourth quarter of 2022 which reflects a one-time release of $6.3 million in deferred maintenance revenue that benefitted Q4 of 2021.
      • During the fourth quarter the Company installed 52 systems compared to 30 systems in the fourth quarter of 2021, of those, 24 systems were under sales and sales-type lease and hybrid JRSA arrangements compared to 26 systems in the prior year.

      Operating Cash Flow and Liquidity

      Net cash provided by operating activities was $17.3 million for full-year 2022, compared to $6.1 million for full-year 2021.

      As of December 31, 2022, the Company's available liquidity was $415.5 million including its balance of cash and cash equivalents of $97.4 million, $275.0 million in available borrowing capacity under the Credit Facility and $43.1 million in available borrowing capacity under IMAX China's revolving facilities. Total debt, excluding deferred financing costs was $270.7 million as of December 31, 2022.

      Share Count and Capital Return

      The weighted average basic and diluted shares outstanding in the fourth quarter of 2022 were 54.8 million and 55.7 million, respectively, compared to 58.9 million and 59.8 million in the fourth quarter of 2021.

      During the fourth quarter of 2022, the Company repurchased 1.9 million shares at an average price of $14.01 for a total of $26.6 million. For the full year, the Company repurchased 5.4 million shares at an average price of $15.19 for a total of $82.0 million and 9.2% of the beginning of year share count.

      In 2021, the Company issued $230.0 million of 0.500% Convertible Senior Notes due 2026 ("Convertible Notes").  In connection with the pricing of the Convertible Notes, the Company entered into privately negotiated capped call transactions with an initial cap price of $37.2750 per share of the Company's common shares.

      Additionally, for the full year, IMAX China repurchased 3.0 million shares at an average price of $1.02 for a total cost of $3.0 million.     

      As of December 31, 2022, a total of $193.4 million remains available under the Company's outstanding share repurchase authorization.

      Supplemental Materials

      For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.

      Investor Relations Website and Social Media

      On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag.

      The Company may post additional information on the Company's corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website in addition to the Company's press releases, SEC filings and public conference calls and webcasts, for additional information about the Company.

      Conference Call

      The Company will host a conference call today at 4:30 PM ET to discuss its fourth quarter 2022 financial results. This call is being webcast and can be accessed at investors.imax.com. To access the call via telephone, interested parties please pre-register here: https://register.vevent.com/register/BI2197088c38524f54b874f4773ab6fb7a. and you will be provided with a dial-in number and unique pin. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. A replay of the call will be available via webcast at investors.imax.com.

      About IMAX Corporation

      IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.

      IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of December 31, 2022, there were 1,716 IMAX systems (1,633 commercial multiplexes, 12 commercial destinations, 71 institutional) operating in 87 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchange under the stock code "1970."

      IMAX®, IMAX® 3D, Experience It In IMAX®, The IMAX Experience®, DMR®, Filmed For IMAX™, IMAX Live™, IMAX Enhanced®, and SSIMWAVE® are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Instagram (https://www.instagram.com/imax), Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

      For additional information please contact:

      Investors:

      IMAX Corporation, New York

      Jennifer Horsley

      212-821-0154

      [email protected]

      Media:
      IMAX Corporation, New York
      Mark Jafar
      212-821-0102

      [email protected]

      Forward-Looking Statements

      This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include, but are not limited to, references to business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), industry prospects and consumer behavior, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the "Company") and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks related to the adverse impact of the COVID-19 pandemic; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada, as well as geopolitical conflicts, such as the conflict between Russia and Ukraine; risks related to the Company's growth and operations in China; the performance of IMAX DMR® films and other films released to the IMAX network; the signing of IMAX System agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates, including competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to consolidation among commercial exhibitors and studios; risks related to brand extensions and new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company's inability to protect the Company's intellectual property; risks related to climate change; risks related to weather conditions and natural disasters that may disrupt or harm the Company's business; risks related to the Company's indebtedness and compliance with its debt agreements; general economic, market or business conditions; risks related to political, economic and social instability, including with respect to the Russia-Ukraine conflict; the failure to convert IMAX System backlog into revenue; changes in laws or regulations; any statements of belief and any statements of assumptions underlying any of the foregoing; other factors and risks outlined in our periodic filings with the SEC; and other factors, many of which are beyond the control of the Company. Consequently, all of the forward-looking statements made in this earnings release are qualified by these cautionary statements, and actual results or anticipated developments by the Company may not be realized, and even if substantially realized, may not have the expected consequences to, or effects on, the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX's most recent Annual Report on Form 10-K. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.

      Primary Reporting Groups

      The Company has the following reportable segments: (i) IMAX DMR; (ii) Joint Revenue Sharing Arrangements ("JRSA"); (iii) IMAX Systems; (iv) IMAX Maintenance; (v) Other Theater Business; (vi) Film Distribution; and (vii) Film Post-Production. The Company's activities that do not meet the criteria to be considered a reportable segment are disclosed within All Other. The Company organizes its reportable segments into the following three categories, identified by the nature of the product sold or service provided:

      (i)  IMAX Technology Network, which earns revenue based on contingent box office receipts and includes the IMAX DMR segment and contingent rent from JRSA segment;

      (ii)  IMAX Technology Sales and Maintenance, which includes results from the IMAX Systems, IMAX Maintenance and Other Theater Business segments, as well as fixed revenues from the JRSA segment; and

      (iii)  Film Distribution and Post-Production, which includes activities related to the distribution of large-format documentary films, primarily to institutional theaters, and the distribution of exclusive experiences ranging from live performances to interactive events with leading artists and creators (through the Film Distribution segment) and the provision of film post-production and quality control services.

      The Company presents its segment information at a disaggregated level to provide more relevant information to the users of its financial statements.

      Transactions between the IMAX DMR segment and the Film Post-Production segment are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.

      In the first quarter of 2022, the Company's internal reporting was updated to reclassify the results of IMAX Enhanced®, an initiative to bring The IMAX Experience® into the home, out of the New Business Initiatives segment and into All Other for segment reporting purposes. IMAX Enhanced was the only component of the New Business Initiatives segment. Prior period comparatives have been reclassified to conform with the current period presentation.

      In the first quarter of 2023, the Company has updated its internal reporting, including the information provided to the CODM to assess segment performance and allocate resources, and, as a result, will update its reportable segments in its quarterly report on Form 10-Q for the period ending March 31, 2023. Following these changes, the Company will have two reportable segments: (i) Technology Products and Services, which will principally include the sale, lease, and maintenance of IMAX Systems, previously included within the JRSA, IMAX Systems, IMAX Maintenance, Other Theater Business segments, and (ii) Content Solutions, which will principally include content enhancement and distribution services, previously included within the IMAX DMR, Film Distribution and Film Post-Production segments. The Company's activities that do not meet the criteria to be considered a reportable segment will be reported within All Other.

      IMAX Network and Backlog 




      Three Months
      Ended December 31,



      Year
      Ended December 31,


      System Signings:


      2022



      2021



      2022



      2021


      New IMAX Systems













      Sales and sales-type lease arrangements



      9




      7




      18




      20


      Hybrid JRSA



      —




      —




      3




      —


      Traditional JRSA



      —




      1




      9




      9


            Total new IMAX Systems



      9




      8




      30




      29


      Upgrades of IMAX systems



      3




      3




      17




      7


         Total IMAX System signings



      12




      11




      47




      36

















      Three Months
      Ended December 31,



      Year
      Ended December 31,


      System Installations:


      2022



      2021



      2022



      2021


      New IMAX Systems(1)













      Sales and sales-type lease arrangements



      14




      18




      28




      35


      Hybrid JRSA



      1




      3




      6




      9


      Traditional JRSA



      6




      3




      22




      18


            Total new IMAX Systems



      21




      24




      56




      62


      Upgrades of IMAX systems



      31




      6




      36




      13


         Total IMAX System installations



      52




      30




      92




      75




      Year
      Ended December 31,



      System Backlog:


      2022




      2021



      Sales and sales-type lease arrangements



      162





      173



      Hybrid JRSA



      120





      132



      Traditional JRSA



      168


      (2)



      184


      (2)

      Total System backlog



      450


      (3)



      489


      (4)












      Year
      Ended December 31,



      System Network:


      2022




      2021



      Commercial Multiplex Systems









      Sales and sales-type lease arrangements



      702





      690



      Hybrid JRSA



      151





      146



      Traditional JRSA



      780





      763



      Total Commercial Multiplex Systems



      1,633





      1,599



      Commercial Destination Systems



      12





      12



      Institutional Systems



      71





      72



      Total System network(5)



      1,716





      1,683



      _______________

      (1)

      For the three months ended December 31, 2022, includes four IMAX Systems that were relocated from their original locations (2021 — nine). For the year ended December 31, 2022, includes twelve IMAX Systems that were relocated from their original location (2021 ― nine). When a system under a sales or sales-type lease arrangement is relocated, the amount of revenue earned by the Company may vary from transaction-to-transaction and is usually less than the amount earned for a new sale. In certain situations when a system is relocated, the original location is upgraded to an IMAX Laser System.



      (2)

      Includes 38 IMAX Systems where the customer has the option to convert from a joint revenue sharing arrangement to a sales arrangement (2021 — 44 ).



      (3)

      Includes 200 new IMAX with Laser projection system configurations and 89 upgrades of existing locations to IMAX Laser Systems configurations.



      (4)

      Includes 158 new IMAX with Laser projection system configurations and 92 upgrades of existing locations to IMAX Laser Systems configurations.



      (5)

      Period-to-period changes are reported net of the effect of permanently closed locations.

      IMAX CORPORATION
      CONSOLIDATED STATEMENTS OF OPERATIONS
      (In thousands of U.S. dollars, except per share amounts)





      Three Months Ended











      December 31,



      Year Ended





      (Unaudited)



      December 31,





      2022



      2021



      2022



      2021


      Revenues













      Technology sales


      $

      33,888



      $

      31,645



      $

      69,158



      $

      66,153


      Image enhancement and maintenance services



      44,094




      54,234




      161,379




      131,148


      Technology rentals



      18,060




      20,082




      61,786




      46,790


      Finance income



      2,004




      2,611




      8,482




      10,792






      98,046




      108,572




      300,805




      254,883


      Costs and expenses applicable to revenues













      Technology sales



      17,346




      19,260




      37,610




      37,039


      Image enhancement and maintenance services



      25,575




      19,480




      81,834




      58,062


      Technology rentals



      6,278




      5,797




      25,006




      25,376






      49,199




      44,537




      144,450




      120,477


      Gross margin



      48,847




      64,035




      156,355




      134,406


      Selling, general and administrative expenses



      37,862




      34,929




      138,043




      117,322


      Research and development



      1,633




      1,248




      5,300




      6,944


      Amortization of intangible assets



      1,417




      1,291




      4,829




      4,877


      Credit loss expense (reversal), net



      398




      933




      8,547




      (3,951)


      Asset impairments



      —




      —




      4,470




      —


      Legal judgment and arbitration awards



      —




      —




      —




      (1,770)


      Income (loss) from operations



      7,537




      25,634




      (4,834)




      10,984


      Realized and unrealized investment (losses) gains



      (29)




      29




      70




      5,340


      Retirement benefits non-service expense



      (139)




      (116)




      (556)




      (463)


      Interest income



      252




      538




      1,428




      2,218


      Interest expense



      (1,523)




      (1,558)




      (5,877)




      (7,092)


      Income (loss) before taxes



      6,098




      24,527




      (9,769)




      10,987


      Income tax expense



      (2,017)




      (11,148)




      (10,108)




      (20,564)


      Net income (loss)



      4,081




      13,379




      (19,877)




      (9,577)


      Net income attributable to non-controlling interests



      (1,468)




      (3,279)




      (2,923)




      (12,752)


      Net income (loss) attributable to common shareholders


      $

      2,613



      $

      10,100



      $

      (22,800)



      $

      (22,329)
















      Net income (loss) per share attributable to common shareholders - basic and diluted:


      Net income (loss) per share — basic and diluted


      $

      0.05



      $

      0.17



      $

      (0.40)



      $

      (0.38)
















      Weighted average shares outstanding (in thousands):



      Basic



      54,816




      58,886




      56,674




      59,126



      Diluted



      55,659




      59,805




      56,674




      59,126


      Additional Disclosure:













      Depreciation and amortization


      $

      13,998



      $

      15,512



      $

      56,661



      $

      56,082


      Amortization of deferred financing costs


      $

      712



      $

      764



      $

      3,177



      $

      2,513


      IMAX CORPORATION
      CONSOLIDATED BALANCE SHEETS
      (In thousands of dollars, except share amounts)




      As of December 31,




      2022



      2021


      Assets







      Cash and cash equivalents


      $

      97,401



      $

      189,711


      Accounts receivable, net of allowance for credit losses



      136,142




      110,050


      Financing receivables, net of allowance for credit losses



      129,384




      141,049


      Variable consideration receivable, net of allowance for credit losses



      44,024




      44,218


      Inventories



      31,534




      26,924


      Prepaid expenses



      12,343




      11,802


      Film assets, net of accumulated amortization



      5,277




      4,241


      Property, plant and equipment, net of accumulated depreciation



      252,896




      260,353


      Investment in equity securities



      1,035




      1,087


      Other assets



      15,665




      17,799


      Deferred income tax assets, net of valuation allowance



      9,900




      13,906


      Goodwill



      52,815




      39,027


      Other intangible assets, net of accumulated amortization



      32,738




      23,080


      Total assets


      $

      821,154



      $

      883,247


      Liabilities







      Accounts payable


      $

      25,237



      $

      15,943


      Accrued and other liabilities



      117,286




      111,896


      Deferred revenue



      70,940




      81,281


      Revolving credit facility borrowings, net of unamortized debt issuance costs



      36,111




      2,472


      Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs


      226,912




      223,641


      Deferred income tax liabilities



      14,900




      17,642


      Total liabilities



      491,386




      452,875


      Commitments, contingencies and guarantees







      Non-controlling interests



      722




      758


      Shareholders' equity







      Capital stock common shares — no par value. Authorized — unlimited number.







      54,148,614 issued and outstanding (December 31, 2021 — 58,653,642 issued and  outstanding)



      376,715




      409,979


      Other equity



      185,678




      174,620


      Statutory surplus reserve



      3,932




      3,932


      Accumulated deficit



      (293,124)




      (234,975)


      Accumulated other comprehensive (loss) income



      (9,846)




      2,527


      Total shareholders' equity attributable to common shareholders



      263,355




      356,083


      Non-controlling interests



      65,691




      73,531


      Total shareholders' equity



      329,046




      429,614


      Total liabilities and shareholders' equity


      $

      821,154



      $

      883,247


      IMAX CORPORATION
      CONSOLIDATED STATEMENTS OF CASH FLOWS
      (In thousands of dollars)





      Years Ended December 31,




      2022



      2021


      Operating Activities









      Net loss


      $


      (19,877)



      $


      (9,577)


      Adjustments to reconcile net loss to cash provided by operating activities:









      Depreciation and amortization




      56,661





      56,082


      Amortization of deferred financing costs




      3,177





      2,513


      Credit loss expense (reversal), net




      8,547





      (3,951)


      Write-downs, including asset impairments




      7,176





      1,764


      Deferred income tax (benefit) expense




      (2,073)





      2,996


      Share-based and other non-cash compensation




      27,573





      26,079


      Unrealized foreign currency exchange loss




      1,108





      256


      Realized and unrealized investment gains




      (70)





      (5,340)


      Changes in assets and liabilities:









      Accounts receivable




      (29,003)





      (52,453)


      Inventories




      (5,529)





      11,451


      Film assets




      (19,598)





      (14,810)


      Deferred revenue




      (11,572)





      (6,591)


      Changes in other operating assets and liabilities




      801





      (2,354)


      Net cash provided by operating activities




      17,321





      6,065


      Investing Activities









      Acquisition of SSIMWAVE Inc., net of cash and cash equivalents acquired




      (15,939)





      —


      Purchase of property, plant and equipment




      (8,424)





      (3,590)


      Investment in equipment for joint revenue sharing arrangements




      (19,803)





      (10,094)


      Interest in film classified as a financial instrument




      (4,731)





      —


      Acquisition of other intangible assets




      (4,394)





      (4,092)


      Proceeds from sale of equity securities




      —





      17,769


      Net cash used in investing activities




      (53,291)





      (7)


      Financing Activities









      Proceeds from issuance of convertible notes, net




      —





      223,675


      Debt issuance costs related to convertible notes




      —





      (1,161)


      Purchase of capped calls related to convertible notes




      —





      (19,067)


      Revolving credit facility borrowings




      37,871





      3,600


      Repayment of revolving credit facility borrowings




      (3,600)





      (307,609)


      Credit facility amendment fees paid




      (2,279)





      (527)


      Repurchase of common shares, IMAX Corporation




      (80,124)





      (13,905)


      Repurchase of common shares, IMAX China




      (3,043)





      (10,060)


      Taxes withheld and paid on employee stock awards vested




      (3,687)





      (3,660)


      Common shares issued - stock options exercised




      —





      883


      Principal payment under finance lease obligations




      (948)





      —


      Dividends paid to non-controlling interests




      (2,704)





      (4,889)


      Net cash used in financing activities




      (58,514)





      (132,720)


      Effects of exchange rate changes on cash




      2,174





      (1,006)


      Decrease in cash and cash equivalents during year




      (92,310)





      (127,668)


      Cash and cash equivalents, beginning of year




      189,711





      317,379


      Cash and cash equivalents, end of year


      $


      97,401



      $


      189,711


      Segment Revenue and Gross Margin (Margin Loss)










      Three Months Ended



      Year Ended




      December 31,



      December 31,




      2022



      2021



      2022



      2021


      Revenue













      IMAX Technology Network













      IMAX DMR


      $

      27,803



      $

      31,221



      $

      94,867



      $

      70,659


      JRSA, contingent rent



      18,060




      20,076




      61,768




      46,184





      45,863




      51,297




      156,635




      116,843


      IMAX Technology Sales and Maintenance













      IMAX Systems



      30,127




      30,543




      62,933




      65,660


      JRSA, fixed fees



      2,318




      1,630




      4,804




      5,406


      IMAX Maintenance



      13,044




      20,143




      56,608




      53,339


      Other Theater Business(1)



      2,558




      1,080




      6,255




      2,363





      48,047




      53,396




      130,600




      126,768


      Film Distribution and Post-Production



      1,517




      1,723




      6,935




      5,724


      Sub-total for reportable segments



      95,427




      106,416




      294,170




      249,335


      All Other(2)



      2,619




      2,156




      6,635




      5,548


      Total


      $

      98,046



      $

      108,572



      $

      300,805



      $

      254,883















      Gross Margin (Margin Loss)













      IMAX Technology Network













      IMAX DMR


      $

      14,999



      $

      22,377



      $

      57,964



      $

      44,782


      JRSA, contingent rent



      12,005




      14,462




      37,394




      21,761





      27,004




      36,839




      95,358




      66,543


      IMAX Technology Sales and Maintenance













      IMAX Systems



      16,697




      13,336




      35,129




      34,982


      JRSA, fixed fees



      510




      560




      589




      1,343


      IMAX Maintenance



      5,466




      12,212




      27,109




      27,572


      Other Theater Business



      493




      129




      807




      398





      23,166




      26,237




      63,634




      64,295


      Film Distribution and Post-Production



      (2,658)




      (149)




      (6,128)




      848


      Sub-total for reportable segments



      47,512




      62,927




      152,864




      131,686


      All Other(2)



      1,335




      1,109




      3,491




      2,721


      Total


      $

      48,847



      $

      64,036



      $

      156,355



      $

      134,407


      ______________

      (1)

      The revenue from this segment principally includes after-market sales of IMAX system parts and 3D glasses. 



      (2)

      All Other includes the results from IMAX Enhanced, SSIMWAVE, and other ancillary activities. In the first quarter of 2022, the Company's internal reporting was updated to reclassify the results of IMAX Enhanced out of the New Business Initiatives segment into All Other for segment reporting purposes. Prior period comparatives have been revised to conform with the current period presentation.

      IMAX CORPORATION
      NON-GAAP FINANCIAL MEASURES
      (in thousands of U.S. dollars)

      In this release, the Company presents adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin as supplemental measures of the Company's performance, which are not recognized under U.S. GAAP. Adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share exclude, where applicable: (i) share-based compensation; (ii) COVID-19 government relief benefits, net, (iii) legal judgment and arbitration awards; (iv) realized and unrealized investment gains or losses, (v) acquisition-related expenses, as well as the related tax impact of these adjustments, and (vi) income taxes resulting from management's decision to no longer indefinitely reinvest the historical earnings of certain foreign subsidiaries.

      The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company's financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net income (loss) attributable to common shareholders. Although share-based compensation is an important aspect of the Company's employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.

      A reconciliation from net income (loss) attributable to common shareholders and the associated per share amounts to adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per diluted share is presented in the table below. Net income (loss) attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.

      In addition to the non-GAAP financial measures discussed above, management also uses "EBITDA," as such term is defined in the Company's Credit Agreement, and which is referred to herein as "Adjusted EBITDA per Credit Facility." As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Adjusted EBITDA per Credit Facility measure is presented to allow a more comprehensive analysis of the Company's operating performance and to provide additional information with respect to the Company's compliance against its Credit Agreement requirements when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry to evaluate, assess and benchmark the Company's results.

      EBITDA is defined as net income or loss excluding (i) income tax expense or benefit; (ii) interest expense, net of interest income; (iii) depreciation and amortization, including film asset amortization; and (iv) amortization of deferred financing costs. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment gains or losses; (iii) acquisition-related expenses; (iv) write-downs, net of recoveries, including asset impairments and credit loss expense; and (v) legal judgment and arbitration awards.

      A reconciliation of net income (loss) attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net income (loss) attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.

      In this release, the Company also presents free cash flow, which is not recognized under U.S. GAAP, as a supplemental measure of the Company's liquidity. Prior to the third quarter of 2022, the Company defined free cash flow as net cash provided by or used in operating activities minus cash used in investing activities (from the Consolidated Statements of Cash Flows). In the third quarter of 2022, the Company updated its definition of free cash flow to deduct only normal recurring capital expenditures, including the Company's investment in joint revenue sharing arrangements, the purchase of property, plant and equipment and the acquisition of other intangible assets (from the  Consolidated Statements of Cash Flows), from net cash provided by or used in operating activities. Management believes that free cash flow is a supplemental measure of the cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.

      These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.

      Adjusted EBITDA per Credit Facility




      For the Three Months Ended December 31, 2022 (1)



      For the Three Months Ended December 31, 2021 (1)




      Attributable to
      Non-controlling



      Less:






      Attributable to
      Non-controlling



      Less:







      Interests and



      Attributable to



      Attributable to



      Interests and



      Attributable to



      Attributable to




      Common



      Non-controlling



      Common



      Common



      Non-controlling



      Common




      Shareholders



      Interests



      Shareholders



      Shareholders



      Interests



      Shareholders


      (In thousands of U.S. Dollars)

























      Reported net income


      $


      4,081



      $


      1,468



      $


      2,613



      $


      13,379



      $


      3,279



      $


      10,100


      Add (subtract):

























      Income tax expense




      2,016





      786





      1,230





      11,148





      1,557





      9,591


      Interest expense, net of interest income




      559





      (15)





      574





      257





      (91)





      348


      Depreciation and amortization, including film asset amortization




      13,998





      1,109





      12,889





      15,512





      1,345





      14,167


      Amortization of deferred financing costs(2)




      712





      —





      712





      764





      —





      764


      EBITDA


      $


      21,366



      $


      3,348



      $


      18,018



      $


      41,060



      $


      6,090



      $


      34,970


      Stock and other non-cash compensation




      8,063





      205





      7,858





      7,521





      290





      7,231


      Realized and unrealized investment losses (gains)




      29





      —





      29





      (29)





      —





      (29)


      Acquisition-related expenses




      166





      —





      166





      —





      —





      —


      Write-downs, including asset impairments and credit loss expense




      1,867





      162





      1,705





      1,819





      (23)





      1,842


      Adjusted EBITDA per Credit Facility


      $


      31,491



      $


      3,715



      $


      27,776



      $


      50,371



      $


      6,357



      $


      44,014


      Revenues attributable to common shareholders(3)




      98,046





      7,273





      90,773





      108,572





      10,738





      97,834


      Adjusted EBITDA margin attributable to common shareholders




      32.1

      %




      51.1

      %




      30.6

      %




      46.4

      %




      59.2

      %




      45.0

      %




























      For the Twelve Months Ended December 31, 2022 (1)



      For the Twelve Months Ended December 31, 2021 (1)




      Attributable to
      Non-controlling



      Less:






      Attributable to
      Non-controlling



      Less:







      Interests and



      Attributable to



      Attributable to



      Interests and



      Attributable to



      Attributable to




      Common



      Non-controlling



      Common



      Common



      Non-controlling



      Common




      Shareholders



      Interests



      Shareholders



      Shareholders



      Interests



      Shareholders


      (In thousands of U.S. Dollars)

























      Reported net loss


      $


      (19,877)



      $


      2,923



      $


      (22,800)



      $


      (9,577)



      $


      12,752



      $


      (22,329)


      Add (subtract):

























      Income tax expense




      10,108





      1,256





      8,852





      20,564





      4,049





      16,515


      Interest expense, net of interest income




      1,272





      (251)





      1,523





      2,362





      (356)





      2,718


      Depreciation and amortization, including film asset
         amortization




      56,661





      4,820





      51,841





      56,082





      5,255





      50,827


      Amortization of deferred financing costs(2)




      3,177





      —





      3,177





      2,513





      —





      2,513


      EBITDA


      $


      51,341



      $


      8,748



      $


      42,593



      $


      71,944



      $


      21,700



      $


      50,244


      Stock and other non-cash compensation




      27,573





      760





      26,813





      26,079





      1,114





      24,965


      Realized and unrealized investment gains




      (70)





      —





      (70)





      (5,340)





      (1,571)





      (3,769)


      Acquisition-related expenses




      1,122





      —





      1,122





      —





      —





      —


      Write-downs (Recoveries), including asset impairments and credit loss expense




      15,723





      1,723





      14,000





      (2,187)





      (1,159)





      (1,028)


      Legal judgment and arbitration awards




      —





      —





      —





      (1,770)





      —





      (1,770)


      Adjusted EBITDA per Credit Facility


      $


      95,689



      $


      11,231



      $


      84,458



      $


      88,726



      $


      20,084



      $


      68,642


      Revenues attributable to common shareholders(3)




      300,805





      20,883





      279,922





      254,883





      33,556





      221,327


      Adjusted EBITDA margin attributable to common shareholders




      31.8

      %




      53.8

      %




      30.2

      %




      34.8

      %




      59.9

      %




      31.0

      %

      ______________

      (1)

      The Senior Secured Net Leverage Ratio is calculated using Adjusted EBITDA per Credit Facility determined on a trailing twelve-month basis.



      (2)

      The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.



      (3)


      (In thousands of U.S. Dollars)


      Three months ended
      December 31, 2022



      Three months ended
      December 31, 2021



      Year ended
      December 31, 2022



      Year ended
      December 31, 2021


      Total revenues






      $


      98,046







      $


      108,572







      $


      300,805






      $


      254,883


      Greater China revenues


      $


      25,728







      $


      37,167







      $


      73,330







      $


      112,801





      Non-controlling interest ownership percentage(4)




      28.27

      %








      28.89

      %








      28.48

      %








      29.75

      %




      Deduction for non-controlling interest share of revenues








      (7,273)









      (10,738)









      (20,883)








      (33,556)


      Revenues attributable to common shareholders






      $


      90,773







      $


      97,834







      $


      279,922






      $


      221,327



         (4)  Weighted average ownership percentage for change in non-controlling interest share

      Adjusted Net Income (Loss) Attributable to Common Shareholders and Adjusted Diluted Per Share Calculations




      Three Months Ended



      Three Months Ended




      December 31, 2022



      December 31, 2021


      (In thousands of U.S. dollars, except per share amounts)


      Net Income



      Diluted EPS



      Net Income



      Diluted EPS


      Net income attributable to common shareholders


      $

      2,613



      $

      0.05



      $

      10,100



      $

      0.17


      Adjustments(1):













      Share-based compensation



      7,730




      0.14




      7,140




      0.12


      COVID-19 government relief benefits, net



      —




      —




      1,674




      0.03


      Realized and unrealized investment losses (gains)



      29




      —




      (29)




      —


      Acquisition-related expenses



      166




      —




      —




      —


      Tax impact on items listed above



      17




      —




      (492)




      (0.01)


      Adjusted net income(1)


      $

      10,555



      $

      0.19



      $

      18,393



      $

      0.31















      Weighted average basic shares outstanding






      54,816







      58,886


      Weighted average diluted shares outstanding






      55,659







      59,805











      Year Ended



      Year Ended




      December 31, 2022



      December 31, 2021


      (In thousands of U.S. dollars, except per share amounts)


      Net (Loss) Income



      Diluted EPS



      Net Loss



      Diluted EPS


      Net loss attributable to common shareholders


      $

      (22,800)



      $

      (0.40)



      $

      (22,329)



      $

      (0.38)


      Adjustments(1):













      Share-based compensation



      26,382




      0.46




      24,815




      0.42


      COVID-19 government relief benefits, net



      (373)




      (0.01)




      (3,839)




      (0.06)


      Legal judgment and arbitration awards



      —




      —




      (1,770)




      (0.03)


      Realized and unrealized investment gains



      (70)




      —




      (3,769)




      (0.06)


      Acquisition-related expenses



      1,122




      0.02




      —




      —


      Tax impact on items listed above



      (1,054)




      (0.02)




      (1,909)




      (0.03)


      Income taxes resulting from management's decision to no longer
      indefinitely reinvest the historical earnings of certain foreign
      subsidiaries



      —




      —




      381




      0.01


      Adjusted net income (loss)(1)


      $

      3,207



      $

      0.06



      $

      (8,420)



      $

      (0.14)















      Weighted average shares outstanding - basic






      56,674







      59,126


      Weighted average shares outstanding - diluted






      57,371







      59,126


      _______________

      (1)

      Reflects amounts attributable to common shareholders.

      Free Cash Flow  






      Three Months Ended



      Year Ended


      (In thousands of U.S. Dollars)


      December 31, 2022



      December 31, 2022


      Net cash provided by operating activities


      $


      16,840



      $


      17,321


      Net cash used in capital expenditures




      (9,584)





      (32,621)


      Free cash flow


      $


      7,256



      $


      (15,300)


      SOURCE IMAX Corporation

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.